A news report published on medpagetoday.com states that a recent examination of the U.S. Food and Drug Administration's adverse event reporting system data shows nearly 40 cases of acute gallbladder disease and three deaths in patients who take glucagon-like peptide-1 (GLP-1) receptor agonists. Glucagon-like peptide-1 receptor … [Read more...] about FDA Data Link Diabetes Drug Class to Gallbladder Disease